Daewon Pharmaceutical Co., Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was KRW 1,296.56 million compared to KRW 641.42 million a year ago. Net income was KRW 23,916.93 million compared to KRW 31,944.35 million a year ago.

Basic earnings per share from continuing operations was KRW 1,140 compared to KRW 1,510 a year ago. Diluted earnings per share from continuing operations was KRW 1,110 compared to KRW 1,478 a year ago. Basic earnings per share was KRW 1,140 compared to KRW 1,510 a year ago.

Diluted earnings per share was KRW 1,110 compared to KRW 1,478 a year ago.